Cargando…

Aspirin treatment and risk of first incident cardiovascular diseases in patients with type 2 diabetes: an observational study from the Swedish National Diabetes Register

OBJECTIVES: To investigate the benefits and risks associated with aspirin treatment in patients with type 2 diabetes and no previous cardiovascular disease (CVD) in clinical practice. DESIGN: Population-based cohort study between 2005 and 2009, mean follow-up 3.9 years. SETTING: Hospital outpatient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ekström, Nils, Cederholm, Jan, Zethelius, Björn, Eliasson, Björn, Fhärm, Eva, Rolandsson, Olov, Miftaraj, Mervete, Svensson, Ann-Marie, Gudbjörnsdottir, Soffia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2013
Materias:	Diabetes and Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641436/ https://www.ncbi.nlm.nih.gov/pubmed/23604419 http://dx.doi.org/10.1136/bmjopen-2013-002688

Ejemplares similares

Durability of oral hypoglycemic agents in drug naïve patients with type 2 diabetes: report from the Swedish National Diabetes Register (NDR)
por: Ekström, Nils, et al.
Publicado: (2015)

Effectiveness and safety of metformin in 51 675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register
por: Ekström, Nils, et al.
Publicado: (2012)

Impact of ethnicity on progress of glycaemic control in 131 935 newly diagnosed patients with type 2 diabetes: a nationwide observational study from the Swedish National Diabetes Register
por: Rawshani, Araz, et al.
Publicado: (2015)

Pros and cons of gastric bypass surgery in individuals with obesity and type 2 diabetes: nationwide, matched, observational cohort study
por: Liakopoulos, Vasileios, et al.
Publicado: (2019)

Association between refill adherence to lipid-lowering medications and the risk of cardiovascular disease and mortality in Swedish patients with type 2 diabetes mellitus: a nationwide cohort study
por: Karlsson, Sofia Axia, et al.
Publicado: (2018)

Clinical Usefulness of Different Lipid Measures for Prediction of Coronary Heart Disease in Type 2 Diabetes: A report from the Swedish National Diabetes Register
por: Eliasson, Björn, et al.
Publicado: (2011)

Clinical Use and Effectiveness of Lipid Lowering Therapies in Diabetes Mellitus—An Observational Study from the Swedish National Diabetes Register
por: Eliasson, Björn, et al.
Publicado: (2011)

Risk Prediction of Cardiovascular Disease in Type 2 Diabetes: A risk equation from the Swedish National Diabetes Register
por: Cederholm, Jan, et al.
Publicado: (2008)

Glycemic Control and Cardiovascular Disease in 7,454 Patients With Type 1 Diabetes: An observational study from the Swedish National Diabetes Register (NDR)
por: Eeg-Olofsson, Katarina, et al.
Publicado: (2010)

Adherence to lipid-lowering therapy and risk for cardiovascular disease and death in type 1 diabetes mellitus: a population-based study from the Swedish National Diabetes Register
por: Hero, Christel, et al.
Publicado: (2020)

What is important for you? A qualitative interview study of living with diabetes and experiences of diabetes care to establish a basis for a tailored Patient-Reported Outcome Measure for the Swedish National Diabetes Register
por: Svedbo Engström, Maria, et al.
Publicado: (2016)

Refill adherence and persistence to lipid‐lowering medicines in patients with type 2 diabetes: A nation‐wide register‐based study
por: Karlsson, Sofia Axia, et al.
Publicado: (2017)

Excess Body Weight and Cancer Risk in Patients with Type 2 Diabetes Who Were Registered in Swedish National Diabetes Register – Register-Based Cohort Study in Sweden
por: Miao Jonasson, Junmei, et al.
Publicado: (2014)

Comparison between data-driven clusters and models based on clinical features to predict outcomes in type 2 diabetes: nationwide observational study
por: Lugner, Moa, et al.
Publicado: (2021)

Prescription of lipid-lowering medications for patients with type 2 diabetes mellitus and risk-associated LDL cholesterol: a nationwide study of guideline adherence from the Swedish National Diabetes Register
por: Karlsson, Sofia Axia, et al.
Publicado: (2018)

HbA1C and Cancer Risk in Patients with Type 2 Diabetes – A Nationwide Population-Based Prospective Cohort Study in Sweden
por: Miao Jonasson, Junmei, et al.
Publicado: (2012)

Impact of Socioeconomic Factors and Gender on Refill Adherence and Persistence to Lipid-Lowering Therapy in Type 1 Diabetes
por: Hero, Christel, et al.
Publicado: (2021)

Range of Risk Factor Levels: Control, Mortality, and Cardiovascular Outcomes in Type 1 Diabetes Mellitus
por: Rawshani, Aidin, et al.
Publicado: (2017)

SAT-378 Thyroid Disease, a Severe Infection, and Glucagon Prescription Should Raise the Awareness of Addison's Disease in Patients with Type 1 Diabetes: A National Swedish Study
por: Chantzichristos, Dimitrios, et al.
Publicado: (2019)

Efficacy and Safety of Treatment with New Basal Insulin Analogues in Type 1 Diabetes: Nation-Wide Survey
por: Svensson, Ann-Marie, et al.
Publicado: (2020)

Predicting Changes in Cardiovascular Risk Factors in Type 2 Diabetes in the Post-UKPDS Era: Longitudinal Analysis of the Swedish National Diabetes Register
por: Ahmad Kiadaliri, Aliasghar, et al.
Publicado: (2013)

Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18 168 people with type 1 diabetes: observational study
por: Steineck, Isabelle, et al.
Publicado: (2015)

Towards Renewed Health Economic Simulation of Type 2 Diabetes: Risk Equations for First and Second Cardiovascular Events from Swedish Register Data
por: Ahmad Kiadaliri, Aliasghar, et al.
Publicado: (2013)

Clinical effects, cardiovascular and renal outcomes associated with rapid-acting insulin analogs among individuals with type 2 diabetes: a nation-wide observational cohort study
por: Svensson, Ann-Marie, et al.
Publicado: (2017)

Changes in risk factors and their contribution to reduction of mortality risk following gastric bypass surgery among obese individuals with type 2 diabetes: a nationwide, matched, observational cohort study
por: Liakopoulos, Vasileios, et al.
Publicado: (2017)

Cardiovascular Disease in Patients with Type 2 Diabetes and in Patients Starting Empagliflozin Treatment: Nationwide Survey
por: Eliasson, Björn, et al.
Publicado: (2019)

Effect of Diabetes on Morbidity and Mortality in Patients With Acromegaly
por: Esposito, Daniela, et al.
Publicado: (2022)

Clinical Effects and Safety of Direct-Acting Insulin Analogs in Patients with Type 1 Diabetes: A Nation-Wide Observational Cohort Study
por: Lak, Vincent, et al.
Publicado: (2016)

Patient-reported outcome and experience measures for diabetes: development of scale models, differences between patient groups and relationships with cardiovascular and diabetes complication risk factors, in a combined registry and survey study in Sweden
por: Borg, Sixten, et al.
Publicado: (2019)

Worse cardiovascular prognosis after endovascular surgery for intermittent claudication caused by infrainguinal atherosclerotic disease in patients with diabetes
por: Dakhel, Ardwan, et al.
Publicado: (2020)

New Diabetes Questionnaire to add patients’ perspectives to diabetes care for adults with type 1 and type 2 diabetes: nationwide cross-sectional study of construct validity assessing associations with generic health-related quality of life and clinical variables
por: Svedbo Engström, Maria, et al.
Publicado: (2020)

Blood pressure and complications in individuals with type 2 diabetes and no previous cardiovascular disease: national population based cohort study
por: Adamsson Eryd, Samuel, et al.
Publicado: (2016)

Treatment persistence in patients with type 2 diabetes treated with glucagon‐like peptide‐1 receptor agonists in clinical practice in Sweden
por: Svensson, Ann‐Marie, et al.
Publicado: (2020)

Cardiorenal and other diabetes related outcomes with SGLT-2 inhibitors compared to GLP-1 receptor agonists in type 2 diabetes: nationwide observational study
por: Lugner, Moa, et al.
Publicado: (2021)

Risk of cardiovascular event and mortality in relation to refill and guideline adherence to lipid-lowering medications among patients with type 2 diabetes mellitus in Sweden
por: Karlsson, Sofia Axia, et al.
Publicado: (2019)

Potential Effects of Bariatric Surgery on the Incidence of Heart Failure and Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus and Obesity and on Mortality in Patients With Preexisting Heart Failure: A Nationwide, Matched, Observational Cohort Study
por: Höskuldsdóttir, Gudrún, et al.
Publicado: (2021)

Short-term progression of cardiometabolic risk factors in relation to age at type 2 diabetes diagnosis: a longitudinal observational study of 100,606 individuals from the Swedish National Diabetes Register
por: Steinarsson, Andri O., et al.
Publicado: (2018)

Diabetes mellitus was not associated with lower amputation-free survival after open revascularization for chronic limb-threatening ischemia – A nationwide propensity score adjusted analysis
por: Lilja, Erika, et al.
Publicado: (2021)

Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study
por: Ueda, Peter, et al.
Publicado: (2018)

Variability in body weight and the risk of cardiovascular complications in type 2 diabetes: results from the Swedish National Diabetes Register
por: Ceriello, Antonio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6fbm1a2lb5n73danavpj6nsk0a